[ad_1] Report on the KFDA Working Report … Recovery by August 8th and "Generic Council" Plan The "Valsartan Crisis", highlighted in the KFDA Report, once again highlights the problem of the safety …
Read More »
[ad_1] The doctor's prescription in the problem of surrender … The Seoul Pharmacists Association (President Kim Jong-hwan) recently announced a statement refuting the statement of the badociation of doctors on the situation …
Read More »
[ad_1] Health authorities have begun a field survey of manufacturers of anti-hypertensive drugs that may develop carcinogens. The Food and Drug Administration is the manufacturer of anti-hypertensive drugs that may contain valsartan, …
Read More »
[ad_1] As the possibility of acting as a carcinogen in the Chinese "Valsartan", used as a treatment for hypertension, was discontinued for 219 hypertension treatments using raw materials. NDA is recalled as …
Read More »